发明名称 ORAL SOLID DOSE VACCINE
摘要 The present invention relates to novel vaccine formulations suitable for oral administration. The vaccine formulations are in a solid form comprising antigen and suitable excipients, which after insertion into the mouth, rapidly dissolve in saliva, thereby releasing the vaccine into the mouth. Specifically, the solid form may consist of a cake of vaccine which is formed from a liquid solution or suspension by sublimation, preferably sublimation by lyophilisation. Preferred vaccines are those containing antigens which are or are derived from pathogens that normally infect or invade the host through a mucosal membrane, or those vaccines that further comprise an antacid. Particularly preferred vaccines are combination vaccines that comprise more than one antigen, and more preferably when the antigens are from more than one pathogen.
申请公布号 PL362481(A1) 申请公布日期 2004.11.02
申请号 PL20010362481 申请日期 2001.08.14
申请人 GLAXOSMITHKLINE BIOLOGICALS SA 发明人 VANDE-VELDE VINCENT
分类号 A61K9/00;A61K9/20;A61K39/00;A61K39/02;A61K39/12;A61K39/145;A61K39/39;A61K47/02;A61K47/04;A61K47/10;A61K47/26;A61K47/36;A61P31/00 主分类号 A61K9/00
代理机构 代理人
主权项
地址